Previous 10 |
home / stock / cphrf / cphrf news
Cipher Pharmaceuticals Appoints Mr. Craig Mull to the Board of Directors Canada NewsWire OAKVILLE, ON, March 26, 2019 OAKVILLE, ON , March 26, 2019 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company") today announced that Mr. Craig Mull was appointe...
Cipher Pharmaceuticals Announces Change to Management Team Canada NewsWire OAKVILLE, ON, March 20, 2019 OAKVILLE, ON , March 20, 2019 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company") today announced that Stephen Lemieux , Chief Financial Officer ...
Cipher Pharmaceuticals Inc. (CPHRF) Q4 2018 Earnings Conference Call March 19, 2019 8:30 A.M. ET Company Participants Robert Tessarolo - President and Chief Executive Officer Stephen Lemieux - Chief Financial Officer and Secretary Conference Call Participants Prasath Panduran...
Cipher Pharmaceuticals ( OTC:CPHRF ): Q4 GAAP EPS of -$0.02. More news on: Cipher Pharmaceuticals Inc., Earnings news and commentary, , Read more ...
Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results Canada NewsWire OAKVILLE, ON, March 19, 2019 Canadian product revenue increased 30% to $6.9 million for the year Completed six (6) strategic business transactions enhancing long-term ...
Notice of Cipher Pharmaceuticals Q4 2018 Conference Call Canada NewsWire OAKVILLE, ON, March 15, 2019 OAKVILLE, ON , March 15, 2019 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company") today announced the details of its Q4 2018 financial results confe...
News, Short Squeeze, Breakout and More Instantly...
Companhia Siderurgica Paulista Nova Cosipa Company Name:
CPHRF Stock Symbol:
OTCMKTS Market:
Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders Canada NewsWire MISSISSAUGA, ON , June 14, 2024 /CNW/ - Cipher Pharmaceuticals Inc . (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the "Company ") today announced that i...
Cipher Pharmaceuticals Reports First Quarter 2024 Results Canada NewsWire (All figures are presented in U.S. Dollars) Adjusted EBITDA in Q1 2024 was $3.6 million , an increase of 12.5% over Q1 2023 Epuris sales volumes grew 7.2% in the quarter over Q1 2023, c...
Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call Canada NewsWire MISSISSAUGA, ON , May 3, 2024 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the " Company ") today announced that it will release ...